According to Mochida Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 5.98%. At the end of 2024 the company had an Operating Margin of 5.99%.
Year | Operating Margin | Change |
---|---|---|
2024 | 5.99% | -31.62% |
2023 | 8.76% | -33.86% |
2022 | 13.24% | 13.64% |
2021 | 11.65% | 34.71% |
2020 | 8.65% | -18.52% |
2019 | 10.62% | -6.47% |
2018 | 11.35% | -4.66% |
2017 | 11.91% | -9.27% |
2016 | 13.13% | 2.61% |
2015 | 12.79% | -24.1% |
2014 | 16.85% | 6.67% |
2013 | 15.80% | -10.35% |
2012 | 17.62% | 70.91% |
2011 | 10.31% | -48.79% |
2010 | 20.14% | 10.08% |
2009 | 18.29% | -3.85% |
2008 | 19.03% | 36.09% |
2007 | 13.98% | 10.07% |
2006 | 12.70% | 111.06% |
2005 | 6.02% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.